Detected ·
Plurify
£1.33M—
Plurify has raised £1.33M to accelerate the development of its patented stem cell therapy purification technology (PluRNA), an RNA-based platform for safer and more scalable cell and gene therapy manufacturing. The round was led by Kadmos Capital with participation from Exceptional Ventures, British Business Bank, and non-dilutive funding from Innovate UK.
- Website
- plurify.bio
- linkedin.com/company/plurifybio
- Amount
- £1 330 000 GBP
- Stage
- —
- Event
- Funding round
- Detected
- 2026-07-22 08:12:30 UTC
- Signal ID
- 5e76cea4-a64a-4dd6-a6f2-0976632b1d13
As the API returns it
{
"id": "5e76cea4-a64a-4dd6-a6f2-0976632b1d13",
"created_at": "2026-07-22T08:12:30.125418Z",
"company_name": "Plurify",
"company_website_url": "plurify.bio",
"company_linkedin_url": "https://www.linkedin.com/company/plurifybio",
"event_type": "funding",
"funding_amount": 1330000,
"funding_currency": "GBP",
"funding_stage": null,
"message": "*Plurify has raised £1.33M to accelerate the development of its patented stem cell therapy purification technology (PluRNA), an RNA-based platform for safer and more scalable cell and gene therapy manufacturing. The round was led by Kadmos Capital with participation from Exceptional Ventures, British Business Bank, and non-dilutive funding from Innovate UK.*"
}